Cargando…
Arterial indications for the low molecular weight heparins
Antithrombotic treatment is of proven importance in patients with acute coronary syndromes. There is now accumulating evidence from several clinical trials in patients with unstable angina pectoris that the low molecular weight heparins (LMWHs) are at least as effective as unfractionated heparin. Th...
Autores principales: | Ageno, Walter, Huisman, Menno V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59526/ https://www.ncbi.nlm.nih.gov/pubmed/11806802 http://dx.doi.org/10.1186/cvm-2-5-233 |
Ejemplares similares
-
Low-molecular-weight heparins in the treatment of venous thromboembolism
por: Ageno , Walter, et al.
Publicado: (2000) -
Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014) -
Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With
Enoxaparin
por: Chen, Jianle, et al.
Publicado: (2019) -
Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
por: Shute, Janis Kay
Publicado: (2023) -
Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas
por: Bokas, Alexandros, et al.
Publicado: (2020)